Amarin Corp Plc (AMRN)

[sts66]

Looks to me from that presentation their only plan is to sell the company - everything is focused on SG&A cost problems caused by being a one-drug company. I do like pg 14 where they say management is way overpaid compared to performance, but they neglect to mention that the rich exec comp plain that was approved in 2020 was based on dreams of riches from gaining R-IT approval, and there was no way to cancel that plan once approved - they also pointed out in one of their presentations why such a horrible for shareholders exec comp plan was approved in the first place - too many retailers didn't bother to vote against it, and a non-vote gets counted as abstaining, which generally counts as a yes vote for the BOD's proposed exec comp plan. That same lack of participation makes me wonder if this proxy fight actually goes anywhere - 'tutes other than Sarissa will likely vote for AMRN's BOD, and with enough abstentions there won't be enough votes cast in favor of Sarissa for them to take over the BOD. I also have a hard time believing Sarissa's claim of only spending $250k on this fight while accusing the BOD of spending $5M-$7M - one of those numbers cannot possibly be anywhere close to accurate.